Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313360942> ?p ?o ?g. }
- W4313360942 endingPage "888" @default.
- W4313360942 startingPage "866" @default.
- W4313360942 abstract "Glioblastoma multiforme (GBM) is known as the most aggressive and prevalent brain tumor with a high mortality rate. It is reported in people who are as young as 10 years old to as old as over 70 years old, exhibiting inter and intra tumor heterogeneity. There are several genomic and proteomic investigations that have been performed to find the unexplored potential targets of the drug against GBM. Therefore, certain effective targets have been taken to further validate the studies embarking on the robustness in the field of medicinal chemistry followed by testing in clinical trials. Also, The Cancer Genome Atlas (TCGA) project has identified certain overexpressed targets involved in the pathogenesis of GBM in three major pathways, i.e., tumor protein 53 (p53), retinoblastoma (RB), and receptor tyrosine kinase (RTK)/rat sarcoma virus (Ras)/phosphoinositide 3-kinase (PI3K) pathways. This review focuses on the compilation of recent developments in the fight against GBM thus, directing future research into the elucidation of pathogenesis and potential cure for GBM. Also, it highlights the potential biomarkers that have undergone extensive research and have promising prognostic and predictive values. Additionally, this manuscript analyses the advent of gene therapy and immunotherapy, unlocking the way to consider treatment approaches other than, or in addition to, conventional chemo-radiation therapies. This review study encompasses all the relevant research studies associated with the pathophysiology, occurrence, diagnostic tools, and therapeutic intervention for GBM. It highlights the evolution of various therapeutic perspectives against GBM from the most conventional form of radiotherapy to the recent advancement of gene/cell/immune therapy. Further, the review focuses on various targeted therapies for GBM including chemotherapy sensitization, radiotherapy, nanoparticles based, immunotherapy, cell therapy, and gene therapy which would offer a comprehensive account for exploring several facets related to GBM prognostics." @default.
- W4313360942 created "2023-01-06" @default.
- W4313360942 creator A5005156249 @default.
- W4313360942 creator A5016907872 @default.
- W4313360942 creator A5029680773 @default.
- W4313360942 creator A5030786068 @default.
- W4313360942 creator A5030875646 @default.
- W4313360942 creator A5044253989 @default.
- W4313360942 creator A5071952491 @default.
- W4313360942 creator A5084231903 @default.
- W4313360942 date "2022-12-30" @default.
- W4313360942 modified "2023-10-14" @default.
- W4313360942 title "New phase therapeutic pursuits for targeted drug delivery in glioblastoma multiforme" @default.
- W4313360942 cites W1571160073 @default.
- W4313360942 cites W1606862586 @default.
- W4313360942 cites W1772765560 @default.
- W4313360942 cites W1773455335 @default.
- W4313360942 cites W1970930921 @default.
- W4313360942 cites W1974637327 @default.
- W4313360942 cites W1976295398 @default.
- W4313360942 cites W1977657574 @default.
- W4313360942 cites W1988141190 @default.
- W4313360942 cites W1995076802 @default.
- W4313360942 cites W1996899753 @default.
- W4313360942 cites W1998220101 @default.
- W4313360942 cites W1998941426 @default.
- W4313360942 cites W2003438982 @default.
- W4313360942 cites W2012817412 @default.
- W4313360942 cites W2013523350 @default.
- W4313360942 cites W2014096417 @default.
- W4313360942 cites W2015619266 @default.
- W4313360942 cites W2024281454 @default.
- W4313360942 cites W2025183726 @default.
- W4313360942 cites W2033488181 @default.
- W4313360942 cites W2034737494 @default.
- W4313360942 cites W2035643452 @default.
- W4313360942 cites W2036938540 @default.
- W4313360942 cites W2037173620 @default.
- W4313360942 cites W2040827479 @default.
- W4313360942 cites W2041908101 @default.
- W4313360942 cites W2043449331 @default.
- W4313360942 cites W2043565940 @default.
- W4313360942 cites W2050431672 @default.
- W4313360942 cites W2052570190 @default.
- W4313360942 cites W2055798428 @default.
- W4313360942 cites W2064876412 @default.
- W4313360942 cites W2068491059 @default.
- W4313360942 cites W2069294039 @default.
- W4313360942 cites W2074883812 @default.
- W4313360942 cites W2081935151 @default.
- W4313360942 cites W2100460498 @default.
- W4313360942 cites W2101812937 @default.
- W4313360942 cites W2102099315 @default.
- W4313360942 cites W2102140960 @default.
- W4313360942 cites W2102142353 @default.
- W4313360942 cites W2103744931 @default.
- W4313360942 cites W2105933029 @default.
- W4313360942 cites W2116713018 @default.
- W4313360942 cites W2124117192 @default.
- W4313360942 cites W2125403904 @default.
- W4313360942 cites W2132052921 @default.
- W4313360942 cites W2151010413 @default.
- W4313360942 cites W2155140015 @default.
- W4313360942 cites W2155146490 @default.
- W4313360942 cites W2158538733 @default.
- W4313360942 cites W2159817656 @default.
- W4313360942 cites W2161541244 @default.
- W4313360942 cites W2163695893 @default.
- W4313360942 cites W2165057712 @default.
- W4313360942 cites W2165418665 @default.
- W4313360942 cites W2171407623 @default.
- W4313360942 cites W2219075584 @default.
- W4313360942 cites W2367516440 @default.
- W4313360942 cites W2415588682 @default.
- W4313360942 cites W2513417361 @default.
- W4313360942 cites W2517055057 @default.
- W4313360942 cites W2526011086 @default.
- W4313360942 cites W2584466409 @default.
- W4313360942 cites W2617919441 @default.
- W4313360942 cites W2623739851 @default.
- W4313360942 cites W2728443677 @default.
- W4313360942 cites W2747016053 @default.
- W4313360942 cites W2748534887 @default.
- W4313360942 cites W2750054069 @default.
- W4313360942 cites W2752942423 @default.
- W4313360942 cites W2756498897 @default.
- W4313360942 cites W2757935580 @default.
- W4313360942 cites W2790388651 @default.
- W4313360942 cites W2796501385 @default.
- W4313360942 cites W2797777176 @default.
- W4313360942 cites W2896006729 @default.
- W4313360942 cites W2896205604 @default.
- W4313360942 cites W2905222036 @default.
- W4313360942 cites W2905538718 @default.
- W4313360942 cites W2908798485 @default.
- W4313360942 cites W2909015916 @default.
- W4313360942 cites W2947197516 @default.
- W4313360942 cites W2952280304 @default.